The DEA's John Mulrooney issued a ruling late Monday that included the cancellation of a marijuana rescheduling hearing set ...

A Drug Enforcement Administration (DEA) judge has advised the head of the agency that the ball is back in her court with ...

A former top DEA official who cast doubt on marijuana rescheduling is President Trump’s interim choice to oversee the agency.

A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana ...

In the latest development in a road to rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act (“CSA”), on ...

The Justice Department is telling a federal court that it should pause a lawsuit challenging the Drug Enforcement ...

A last-minute Biden administration effort to loosen restrictions on marijuana by rescheduling, or reclassifying it, as a less ...

Administrative Law Judge (ALJ) John Mulrooney has cancelled the long-awaited cannabis re-scheduling hearing set for next week. Pro-reform advocates have suggested that the DEA had improper ...

In a major victory for the the cannabis industry, President Biden has commuted the sentences of nearly 2,500 individuals ...

Had we not intervened, the hearing would have gone ahead with DEA openly tipping the scales against rescheduling.” By Michael ...

Philip Morris International (PMI), through its subsidiary Vectura Fertin Pharma, partnered with Avicanna AVCNF to advance cannabinoid-based medicine. The deal underscores PMI's strategic focus on ...

Administrative Law Judge John Mulrooney postponed a pivotal hearing, citing allegations of misconduct within the DEA. Advocates had accused the agency of improper communications with anti-cannabis ...